D.E. Shaw & Co
RMD icon

D.E. Shaw & Co’s ResMed RMD Stock Holding History

D.E. Shaw & Co’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.6M Sell
11,576
-12,013
-51% -$2.99M ﹤0.01% 2712
2025
Q4 		$5.68M Sell
23,589
-1,127
-5% -$288K ﹤0.01% 2201
2025
Q3 		$6.77M Sell
24,716
-3,061
-11% -$836K ﹤0.01% 1972
2025
Q2 		$7.17M Buy
27,777
+10,135
+57% +$2.42M 0.01% 1749
2025
Q1 		$3.95M Buy
17,642
+11,092
+169% +$2.59M ﹤0.01% 2078
2024
Q4 		$1.5M Sell
6,550
-8,714
-57% -$2.1M ﹤0.01% 2943
2024
Q3 		$3.73M Buy
15,264
+13,064
+594% +$2.92M ﹤0.01% 2187
2024
Q2 		$421K Sell
2,200
-4,415
-67% -$896K ﹤0.01% 3732
2024
Q1 		$1.31M Sell
6,615
-34,868
-84% -$6.39M ﹤0.01% 2914
2023
Q4 		$7.14M Sell
41,483
-615,850
-94% -$94.6M 0.01% 1629
2023
Q3 		$97.2M Buy
657,333
+465,392
+242% +$84.1M 0.1% 229
2023
Q2 		$41.9M Buy
191,941
+30,990
+19% +$6.91M 0.04% 499
2023
Q1 		$35.2M Buy
+160,951
New +$34.9M 0.04% 581
2022
Q3 		– Sell
-12,435
Closed -$2.83M – 5477
2022
Q2 		$2.61M Buy
12,435
+9,487
+322% +$2.02M ﹤0.01% 2831
2022
Q1 		$715K Buy
2,948
+99
+3% +$23.9K ﹤0.01% 4149
2021
Q4 		$742K Buy
+2,849
New +$739K ﹤0.01% 4155
2021
Q3 		– Sell
-1,603
Closed -$438K – 5184
2021
Q2 		$395K Sell
1,603
-175,581
-99% -$36.9M ﹤0.01% 4144
2021
Q1 		$34.4M Buy
177,184
+173,932
+5,348% +$34.9M 0.03% 656
2020
Q4 		$691K Sell
3,252
-2,100
-39% -$419K ﹤0.01% 3240
2020
Q3 		$917K Buy
5,352
+3,796
+244% +$701K ﹤0.01% 2917
2020
Q2 		$299K Sell
1,556
-58
-4% -$9.49K ﹤0.01% 3631
2020
Q1 		$238K Buy
1,614
+200
+14% +$31.9K ﹤0.01% 3578
2019
Q4 		$219K Sell
1,414
-3,785
-73% -$546K ﹤0.01% 3769
2019
Q3 		$702K Buy
5,199
+1,985
+62% +$260K ﹤0.01% 3041
2019
Q2 		$392K Sell
3,214
-71,019
-96% -$7.87M ﹤0.01% 3187
2019
Q1 		$7.72M Sell
74,233
-207,971
-74% -$21.5M 0.01% 1272
2018
Q4 		$32.1M Sell
282,204
-247,353
-47% -$26.5M 0.04% 494
2018
Q3 		$61.1M Buy
529,557
+393,221
+288% +$43.1M 0.07% 329
2018
Q2 		$14.1M Buy
136,336
+99,764
+273% +$10.1M 0.02% 904
2018
Q1 		$3.6M Buy
36,572
+31,322
+597% +$2.96M ﹤0.01% 1629
2017
Q4 		$445K Buy
+5,250
New +$434K ﹤0.01% 3046
2017
Q3 		– Sell
-3,626
Closed -$282K – 3580
2017
Q2 		$282K Buy
+3,626
New +$259K ﹤0.01% 3055
2016
Q4 		– Sell
-20,009
Closed -$1.3M – 3578
2016
Q3 		$1.3M Sell
20,009
-134,837
-87% -$8.98M ﹤0.01% 2225
2016
Q2 		$9.79M Sell
154,846
-261,242
-63% -$15.4M 0.02% 906
2016
Q1 		$24.1M Buy
416,088
+343,915
+477% +$19.5M 0.04% 473
2015
Q4 		$3.88M Buy
72,173
+29,698
+70% +$1.67M 0.01% 1607
2015
Q3 		$2.17M Buy
+42,475
New +$2.29M ﹤0.01% 2042
2015
Q2 		– Sell
-26,892
Closed -$1.7M – 3850
2015
Q1 		$1.93M Buy
26,892
+13,988
+108% +$909K ﹤0.01% 2041
2014
Q4 		$723K Buy
12,904
+2,942
+30% +$154K ﹤0.01% 3068
2014
Q3 		$491K Buy
9,962
+762
+8% +$38.8K ﹤0.01% 3370
2014
Q2 		$466K Buy
9,200
+1,046
+13% +$51.8K ﹤0.01% 3590
2014
Q1 		$364K Sell
8,154
-18,000
-69% -$809K ﹤0.01% 3815
2013
Q4 		$1.23M Buy
+26,154
New +$1.32M ﹤0.01% 2989
2013
Q3 		– Sell
-5,748
Closed -$259K – 4432
2013
Q2 		$259K Buy
+5,748
New +$273K ﹤0.01% 3647

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D.E. Shaw & Co's RMD Position: Q1 2026 in Review

D.E. Shaw & Co reduced its ResMed (RMD) stake by 51% in Q1 2026, selling an estimated $2.99M and leaving 11,576 shares worth $2.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2712.

D.E. Shaw & Co first reported a position in RMD in Q2 2013 and has held it in 44 quarters since. The position peaked at $97.2M in Q3 2023. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • D.E. Shaw & Co held 11,576 shares of ResMed worth $2.6M as of Q1 2026.
  • D.E. Shaw & Co sold 12,013 ResMed shares in Q1 2026, an estimated $2.99M.
  • ResMed made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2712 holding.
  • D.E. Shaw & Co first reported a position in ResMed in Q2 2013 and has held it in 44 quarters since.
  • D.E. Shaw & Co's ResMed position peaked at $97.2M in Q3 2023.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.